Back to Trades
Sell4
LEMAITRE VASCULAR INC
LMAT
Total Value
$22.1M
Net $22.0M sold
Sales
$22.0M
2 transactions
Company Information
- Company Name
- LEMAITRE VASCULAR INC
- Ticker Symbol
- LMAT
- CIK
- 0001158895
Insider Information
- Role
- Insider
- Location
- BURLINGTON, MA
Filing Details
- Filing Date
- Mar 2, 2026
- Transaction Date
- Feb 26, 2026
- Accession Number
- 0001193125-26-086259
- Form Type
- 4
- Net Trading Amount
- -$22.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | 150,000 | $106.76 | Sale | $16.0M |
| Feb 26, 2026 | Common Stock | 5,609 | — | Grant/Award | — |
| Feb 26, 2026 | Common Stock | 13 | — | Exercise | — |
| Feb 26, 2026 | Common Stock | 496 | $113.69 | Tax Withholding | $56.4K |
| Mar 2, 2026 | Common Stock | 5,000 | — | Bona Fide Gift | — |
| Mar 2, 2026 | Common Stock | 55,930 | $107.81 | Sale | $6.0M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 | Derivative | 13 | — | Exercise | — |
Footnotes
- (F1)Sold pursuant to a 10b5-1(c) plan adopted 03-10-2025.
- (F2)The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $103.05 to $113.50. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- (F3)These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years.
- (F4)Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- (F5)These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- (F6)The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.95 to $109.49. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- (F7)These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
- (F8)These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.